Matrilineal inheritance of complex I dysfunction m a multigenerational Parkinson's disease family

Annals of Neurology

Volumn 44, Issue 6, 1998, Pages 873-881

  Swerdlow, Russell H ^a   Parks, Janice K ^a   Davis II, John N ^a   Cassarino, David S ^a   Trimmer, Patricia A ^a   Currie, Lillian J ^a   Dougherty, John ^b   Bridges, W Scott ^b   Bennett Jr , James P ^a   Wooten, G Frederick ^a   Parker, W Davis ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Knoxville Neurology Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA;

ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; NEUROBLASTOMA CELL; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PARKINSON DISEASE; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

EID: 0031792679     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440605     Document Type: Article

References (35)

1. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
2. Scott WK, Stajich JM, Yamaoka LH, et al. Genetic complexity and Parkinson's disease. Science 1997;277:387-388
3. Gasser T, Muller-Myhhsok B, Wszolek ZK, et al. Genetic complexity and Parkinson's disease. Science 1997;277:388-389
4. Zareparsi S, Kay J, Camicoli R, et al. Analysis of the α-synuclein G209A mutation in familial Parkinson's disease. Lancet 1998;351:37-38
5. 209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998;50: 513-514
6. Tanner CM, Ottman R, Ellenberg EH, et al. Parkinson's disease (PD) concordance in elderly male monozygotic (MZ) and dizygotic (DZ) twins. Neurology 1997;48(Suppl 2):A333 (Abstract)
7. Johns DR. Mitochondrial DNA and disease. N Engl J Med 1995;333:638-644
8. lys-mutation. Cell 1990;61:931-937
9. leu(UUR) gene associated with MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653
10. Newman NJ. Leber's hereditary optic neuropathy. Arch Neurol 1993;50:540-548
11. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290:457-465
12. Chomyn A, Mariottini P, Cleeter MW, et al. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 1985;314:592-597
13. Mariottini P, Chomyn A, Riley M, et al. Identification of the polypeptides encoded in the unassigned reading frames 2, 4, 4L, and 5 of human mitochondrial DNA. Proc Natl Acad Sci USA 1986;83:1563-1567
14. Chomyn A, Cleeter MW, Ragan CI, et al. URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science 1986;234:614-618
15. Howell N, McCullough DA, Kubacka I, et al. The sequence of human mtDNA: the question of errors versus polymorphisms. Am J Hum Genet 1992;50:1333-1337
16. Parker WD, Boyson SJ, Parks JK. Electron transport chain abnormalities in idiopathic Parkinson's disease. Ann Neurol 1989; 26:719-723
17. Schapira AHV, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;1: 1289 (Letter)
18. Mizuno Y, Ohta S, Tanaka M, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989;163:1450-1455
19. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-671
20. Gu M, Cooper JM, Schapira AHV. Genomic transplantation to determine the molecular basis and pathogenic role of complex I deficiency in Parkinson's disease. Mov Disord 1997;12(Suppl 1):2 (Abstract)
21. Davis RE, Miller S, Hernnstadt C, et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1997;94:4564-4569
22. Hirano M, Shtilbans A, Mayeux R, et al. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci USA 1997;94:14894-14899
23. Wallace DC, Stugard C, Murdock D, et al. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 1997;94:14900-14905
24. Davis JN, Parker WD. Evidence that two reports of mtDNA cytochrome c oxidase mutations in Alzheimer's disease are based on nDNA pseudogenes of recent evolutionary origin. Biochem Biophys Res Commun 1998;244:877-883
25. Wooten GF, Currie LJ, Bennett JP Jr, et al. Maternal inheritance in two large kindreds with Parkinson's disease. Neurology 1997;48(Suppl 2):A333 (Abstract)
26. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH, eds. Advances in neurology, vol 53: Parkinson's disease: anatomy, pathology, and therapy. New York: Raven Press, 1990:245-249
27. Miller SW, Trimmer PA, Parker WD Jr, Davis RE. Creation and characterization of mitochondrial DNA depleted cell lines with "neuronal-like" properties. J Neurochem 1996;67:1897-1907
28. Swerdlow RH, Parks JK, Cassarino DS, et al. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 1997;49:918-925
29. Cassarino DS, Fall CP, Swerdlow RH, et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1997;1362:77-86
30. 2 in cultured endothelial cells. Arch Biochem Biophys 1993;302:348-355
31. Law PK, Saito A, Fleischer S. Study of neurotrophin in normal/ dystrophic parabiotic mice. Exp Neurol 1983;80:761-782
32. Golbe LI, Di Iorio G, Bonavita V, et al. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 1990;27: 276-282
33. Lazzarini AM, Myers RH, Zimmerman TR, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506
34. Morrison PJ, Godwin-Austen RB, Raeburn JA. Familial autosomal dominant dopa responsive Parkinson's disease in three living generations showing extreme anticipation and childhood onset. J Med Gen 1996;33:504-506
35. Christie-Pope BC, Burns RS, Whetsell WO Jr. Ultrastructural alterations induced by 1-methyl-4-phenyl-pyridinium (MPP+) in canine substantia nigra and rat mesencephalon in vitro. Exp Neurol 1989;104:235-240